These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6320142)

  • 1. [Immunological status in small cell and squamous cell lung cancer].
    Janicka G; Przylipiak M; Chyczewska E; Kowal E
    Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated cells in the peripheral blood in lung cancer].
    Qian L
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
    Janicka G; Chyczewska E; Przylipiak M; Kowal E
    Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 6. E rosettes in the uranium miners with lung cancer.
    Kudrna K; Andrlíková J; Smíd A; Stipl Z
    Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
    Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic value of the assessment of nonspecific immunologic reactivity in lung cancer].
    Porwit-Ksiazek A
    Nowotwory; 1982; 32(1-2):71-80. PubMed ID: 6294626
    [No Abstract]   [Full Text] [Related]  

  • 9. [CEA distribution in BALF of lung cancer patients].
    Xu WB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):371-3. PubMed ID: 2855411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phagocytic activity in various lung tumors].
    Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
    Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating immunocomplexes in lung neoplasms].
    Pesek M; Sefrna F; Simecek C; Racek J
    Vnitr Lek; 1982 Jun; 28(6):571-6. PubMed ID: 6287725
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
    Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
    Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cellular immunity in pulmonary sarcoidosis and primary lung cancer].
    Li JP
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):100-2, 128. PubMed ID: 1327551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
    Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
    Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N; Nakamura H; Tanaka Y; Ohgi S
    Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of CEA and ferritin in lung cancer before, during and after radiotherapy].
    Tatsuno I; Konishi K
    Rinsho Hoshasen; 1983 Nov; 28(12):1487-90. PubMed ID: 6323796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.